Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Levetiracetam Differentially Alters CD95 Expression of Neuronal Cells and the Mitochondrial Membrane Potential of Immune and Neuronal Cells in vitro.

Rogers SK, Shapiro LA, Tobin RP, Tow B, Zuzek A, Mukherjee S, Newell-Rogers MK.

Front Neurol. 2014 Feb 18;5:17. doi: 10.3389/fneur.2014.00017. eCollection 2014.

PMID:
24600432
[PubMed]
Free PMC Article
2.

Levetiracetam: a review of its use in epilepsy.

Lyseng-Williamson KA.

Drugs. 2011 Mar 5;71(4):489-514. doi: 10.2165/11204490-000000000-00000. Review.

PMID:
21395360
[PubMed - indexed for MEDLINE]
3.

Spotlight on levetiracetam in epilepsy.

Lyseng-Williamson KA.

CNS Drugs. 2011 Oct 1;25(10):901-5. doi: 10.2165/11208340-000000000-00000. Review.

PMID:
21936590
[PubMed - indexed for MEDLINE]
4.

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.

Matagne A, Margineanu DG, Kenda B, Michel P, Klitgaard H.

Br J Pharmacol. 2008 Aug;154(8):1662-71. doi: 10.1038/bjp.2008.198. Epub 2008 May 26.

PMID:
18500360
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

PMID:
15842952
[PubMed - indexed for MEDLINE]
Free Article
6.

Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.

Chaisewikul R, Privitera MD, Hutton JL, Marson AG.

Cochrane Database Syst Rev. 2001;(1):CD001901. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD001901.

PMID:
11279737
[PubMed - indexed for MEDLINE]
7.

Levetiracetam in childhood epilepsy.

Verrotti A, D'Adamo E, Parisi P, Chiarelli F, Curatolo P.

Paediatr Drugs. 2010 Jun;12(3):177-86. doi: 10.2165/11316250-000000000-00000. Review.

PMID:
20486734
[PubMed - indexed for MEDLINE]
9.

Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury.

Jones KE, Puccio AM, Harshman KJ, Falcione B, Benedict N, Jankowitz BT, Stippler M, Fischer M, Sauber-Schatz EK, Fabio A, Darby JM, Okonkwo DO.

Neurosurg Focus. 2008 Oct;25(4):E3. doi: 10.3171/FOC.2008.25.10.E3.

PMID:
18828701
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?

Klitgaard H.

Epilepsia. 2001;42 Suppl 4:13-8. Review.

PMID:
11564119
[PubMed - indexed for MEDLINE]
11.

[Antiepileptic drugs in North America].

Akiyama T, Otsubo H.

Brain Nerve. 2010 May;62(5):519-26. Review. Japanese.

PMID:
20450099
[PubMed - indexed for MEDLINE]
12.

Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.

Surges R, Volynski KE, Walker MC.

Ther Adv Neurol Disord. 2008 Jul;1(1):13-24. doi: 10.1177/1756285608094212. Erratum in: Ther Adv Neurol Disord. 2008 Sep;1(2):79.

PMID:
21180561
[PubMed]
Free PMC Article
13.

Levetiracetam: its use in partial-onset seizure.

Pellock JM, Sankar R.

Expert Rev Neurother. 2003 Nov;3(6):751-60. doi: 10.1586/14737175.3.6.751.

PMID:
19810878
[PubMed]
14.

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.

Klitgaard H, Matagne A, Gobert J, Wülfert E.

Eur J Pharmacol. 1998 Jul 24;353(2-3):191-206.

PMID:
9726649
[PubMed - indexed for MEDLINE]
15.

H(2)O(2) induces upregulation of Fas and Fas ligand expression in NGF-differentiated PC12 cells: modulation by cAMP.

Facchinetti F, Furegato S, Terrazzino S, Leon A.

J Neurosci Res. 2002 Jul 15;69(2):178-88.

PMID:
12111799
[PubMed - indexed for MEDLINE]
16.

Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.

Dooley M, Plosker GL.

Drugs. 2000 Oct;60(4):871-93. Review.

PMID:
11085199
[PubMed - indexed for MEDLINE]
17.

Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures.

Ulloa CM, Towfigh A, Safdieh J.

Neuropsychiatr Dis Treat. 2009;5:467-76. Epub 2009 Sep 15.

PMID:
19777068
[PubMed]
Free PMC Article
18.

Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.

Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J; N166 Levetiracetam Study Group.

Neurology. 2008 Feb 19;70(8):607-16. doi: 10.1212/01.wnl.0000297512.18364.40.

PMID:
18285535
[PubMed - indexed for MEDLINE]
19.

Preliminary efficacy of levetiracetam in monotherapy.

Ben-Menachem E.

Epileptic Disord. 2003 May;5 Suppl 1:S51-5. Review.

PMID:
12915342
[PubMed - indexed for MEDLINE]
20.

Levetiracetam monotherapy in children with epilepsy.

Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A.

Pediatr Neurol. 2007 Apr;36(4):227-30.

PMID:
17437904
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk